CBL-514 injection for reducing belly fat
Treatments studied
This study tests whether CBL-514, an injectable medication, can safely reduce unwanted fat deposits under the skin in the abdomen. If it works, it could offer people a non-surgical option to improve the appearance of belly fat they're unhappy with.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with a healthy weight range (BMI between 18.5–30)
- You have moderate to severe belly fat that bothers you
- You have not had surgery or procedures in the treatment area
- You are not pregnant, nursing, or trying to become pregnant (and willing to use contraception)
- You do not have uncontrolled heart disease, liver or kidney problems, or active cancer
- You are not taking weight-loss medications, GLP-1 drugs (like Ozempic), or strong steroid medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection called CBL-514 to reduce stubborn belly fat in people who are at a healthy weight but have moderate to severe abdominal fat. It may be an option if you've kept a stable lifestyle and are looking for a non-surgical approach.
This study checks if the effects of a previous fat-reducing treatment (CBL-514) last over time and if it remains safe. It's for people who already completed an earlier study with this treatment.
This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.
This study tests a new injectable medication (CBL-514) designed to reduce stubborn fat under the skin in the abdominal area. Researchers will evaluate how well it works, its safety, and how patients tolerate it.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.
Hear when a new Subcutaneous Fat trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.